| 1 |
35296646 |
10.1038/s41419-022-04684-1 |
2022 |
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma. |
NFKBIA |
| 2 |
35600392 |
10.3389/fonc.2022.881801 |
2022 |
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. |
NFKBIA |
| 3 |
35885481 |
10.3390/diagnostics12071575 |
2022 |
Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma. |
NFKBIA |
| 4 |
32961552 |
10.1182/blood.2020007507 |
2021 |
Mutational landscape of gray zone lymphoma. |
NFKBIA |
| 5 |
34405005 |
10.7150/jca.60390 |
2021 |
Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment. |
NFKBIA |
| 6 |
30887112 |
10.1007/s00109-019-01777-x |
2019 |
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α. |
NFKBIA |
| 7 |
27566587 |
10.18632/oncotarget.11548 |
2016 |
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas. |
NFKBIA |
| 8 |
21526201 |
10.1371/journal.pone.0018933 |
2011 |
Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement. |
NFKBIA |
| 9 |
21896478 |
10.1074/jbc.M111.263384 |
2011 |
The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation. |
NFKBIA |
| 10 |
20466000 |
10.1016/j.yexcr.2010.05.004 |
2010 |
Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations. |
NFKBIA |
| 11 |
20937806 |
10.1074/jbc.M110.159681 |
2010 |
Tumor necrosis factor alpha-induced inflammation is increased but apoptosis is inhibited by common food additive carrageenan. |
NFKBIA |
| 12 |
19219072 |
10.1038/onc.2009.6 |
2009 |
Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. |
NFKBIA |
| 13 |
19573080 |
10.1111/j.1365-2141.2009.07790.x |
2009 |
Common genetic variants in candidate genes and risk of familial lymphoid malignancies. |
NFKBIA |
| 14 |
19773279 |
10.1136/oem.2008.044024 |
2009 |
Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. |
NFKBIA |
| 15 |
18235046 |
10.1182/blood-2007-08-108654 |
2008 |
PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor. |
NFKBIA |
| 16 |
18636124 |
10.1371/journal.pone.0002816 |
2008 |
Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. |
NFKBIA |
| 17 |
17540779 |
10.1152/ajpgi.00149.2007 |
2007 |
Bcl10 mediates LPS-induced activation of NF-kappaB and IL-8 in human intestinal epithelial cells. |
NFKBIA |
Datasets
Models
